ALLYSON GARRISON: Open Payments
NPI 1073854956 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 32 payments from 11 companies in 2025. Trend: 2023 $863 · 2024 $897 · 2025 $877
Food & beverage: $777Education: $100
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $158 |
| ABBVIE INC. | 7 | $150 |
| Incyte Corporation | 5 | $117 |
| GENZYME CORPORATION | 3 | $107 |
| UCB, Inc. | 2 | $76 |
| PFIZER INC. | 3 | $74 |
| Janssen Biotech, Inc. | 3 | $61 |
| Amgen Inc. | 2 | $60 |
| Almirall LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: OPZELURA, DUPIXENT, Bimzelx, CIBINQO, BOTOX, TREMFYA, OTEZLA, ILUMYA.
Industry payments across SC — which companies pay providers there.
